The PepGen team looks forward to participating in the 30th Annual Congress of the @WorldMuscleSoc, beginning October 7 in Vienna, Austria. Our data will be presented in two oral presentations, including one on the previously reported positive FREEDOM-DM1 Phase 1 data. More details on our upcoming presentations can be found here: https://lnkd.in/eFyb4CuR
PepGen
Biotechnology Research
Boston, Massachusetts 11,774 followers
Better Technology. Better Delivery. Developing a new generation of disease-modifying therapies.
About us
Driven by our proprietary Enhanced Delivery Oligonucleotide (EDO) platform, we are creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic neuromuscular and neurological disorders.
- Website
-
http://pepgen.com
External link for PepGen
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Boston, Massachusetts
- Type
- Public Company
- Founded
- 2018
- Specialties
- Biotechnology, Chemistry, Biology, Bioscience, Life sciences, and Therapeutics
Locations
-
Primary
Get directions
321 Harrison Ave
8th Floor
Boston, Massachusetts 02118, US
Employees at PepGen
-
Teresa Raimondi
-
James McArthur
Chief Executive Officer at PepGen
-
Jim Dolan
3,000+ Jobs Created | C-Level Growth Strategist | FDI | Public-Private Partnerships | Economic Diplomacy | Government Liaison to B2B Tech
-
Lisa Wyman
Life Sciences Executive | Technical Operations & AI-Enabled Drug Development | Board Leadership & Value Creation
Updates
-
PepGen is proud to support #MDAstrong
Turning Isolation Into Connection 💙💛 Whether you're seeking support, looking to give back, or just starting your journey, MDA is here for you. Every story matters: 🌟 A parent finds clarity and direction through the MDA Resource Center 🌟 A child who’s never met anyone else with a neuromuscular disease makes lifelong friends at MDA Summer Camp 🌟 A young adult discovers purpose and belonging through volunteering #MDAstrong means building connection, community, and hope together. 💪 What does strong mean to you? View other stories and share your own on our website at https://www.mdastrong.org #Connection #Community #Hope #MDA75 #Neuromuscular #MuscularDystrophyAwarenessMonth
-
-
Last week, PepGen announced exciting results from the 15 mg/kg cohort of our FREEDOM-DM1 Phase 1 trial, demonstrating the highest mean splicing correction ever reported in DM1 patients to date. In case you missed it, you can read the full press release here: https://lnkd.in/eCKxc6cU
-
In August, we hosted a panel featuring three incredible #DM1 community members in celebration of #InternationalMyotonicDystrophyAwarenessDay. Watch this video for some highlights of the day.
-
PepGen is proud to support #MyotonicDystrophy Awareness Day.
🌍 60+ Global Alliance Organizations Recognize the 5th annual International #MyotonicDystrophy Awareness Day! 💚 We proudly celebrate the remarkable strength & resilience of the DM community around the world. 🌟 Read the full press release at https://lnkd.in/gpbPuK5X
-
-
Today is #InternationalMyotonicDystrophyAwarenessDay. Today and every day, PepGen is committed to the #DM1 community. We are proud to be an International Myotonic Dystrophy Day Alliance Member. Learn more at https://lnkd.in/gS2iCTB Myotonic Dystrophy Foundation #MyotonicStrong #MyotonicDystrophy #MyotonicDystrophyAwareness
-
Last week, our Pioneers had a blast volunteering with Science Club for Girls! Together, our group assembled 289 curriculum packets to support their virtual STEM sessions that will bring hands-on learning to girls and gender-expansive youth across the community. We’re proud to contribute to a mission that empowers the next generation of young scientists, innovators, and changemakers.
-
-
-
-
-
+1
-
-
This month is muscular dystrophy awareness month. In honor of Muscular Dystrophy Association's #MDAstrong campaign, our VP, Clinical Science, Jane Larkindale, is sharing what strong means in our work at PepGen. #Advocacy #MDAwarenessMonth #MyotonicDystrophy #DM1